Results 31 to 40 of about 49,093 (269)

Racial stereotyping: survey of psychiatrists in the United Kingdom [PDF]

open access: yes, 2001
No abstracts ...
Gillies, M.F.   +3 more
core   +2 more sources

Examining the effect of salbutamol use in ozone air pollution by people with exercise-induced bronchoconstriction. [PDF]

open access: yesPhysiol Rep
Previous studies based on animal models have raised concerns about salbutamol use in ozone air pollution with regard to ozone related lung injury. We conducted a double‐blind, randomized, placebo‐controlled crossover study including 18 subjects diagnosed
Stothers BT   +9 more
europepmc   +2 more sources

Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events [PDF]

open access: yes, 2012
An increase in serious adverse events with both regular formoterol and regular salmeterol in chronic asthma has been demonstrated in previous Cochrane reviews.ObjectivesWe set out to compare the risks of mortality and non-fatal serious adverse events in ...
Altman   +18 more
core   +1 more source

Nebulized heparin and salbutamol versus salbutamol alone in acute exacerbations of chronic obstructive pulmonary disease requiring mechanical ventilation: a double-blind randomized controlled trial [PDF]

open access: yesKorean Journal of Anesthesiology, 2020
Background Nebulized heparin has been effectively used in the management of many pulmonary diseases. However, its effect on mechanically ventilated patients with acute exacerbation chronic obstructive pulmonary disease (AECOPD) has never been studied ...
Tarek Mohamed Ashoor   +2 more
doaj   +1 more source

Effect of single doses of S-salbutamol, R-salbutamol, racemic salbutamol, and placebo on the airway response to methacholine. [PDF]

open access: yesThorax, 1997
Commercially available salbutamol is a racemic mixture consisting of equal amounts of the two enantiomers, R-salbutamol and S-salbutamol, felt to be active and inert, respectively.A double blind, randomised, four way, crossover study was performed in 12 well controlled asthmatic subjects (forced expiratory volume in one second (FEV1) > 70% predicted ...
Donald W. Cockcroft, V A Swystun
openaire   +3 more sources

Onset of bronchodilation with fluticasone/formoterol combination versus fluticasone/salmeterol in an open-label, randomized study [PDF]

open access: yes, 2012
Introduction: The inhaled corticosteroid, fluticasone propionate (fluticasone), and the long-acting beta2-agonist, formoterol fumarate (formoterol), have been combined in a single aerosol inhaler (fluticasone/formoterol).
Aalbers, René   +4 more
core   +1 more source

Formoterol versus short-acting beta-agonists as relief medication for adults and children with asthma [PDF]

open access: yes, 2010
Background Formoterol is a long-acting beta(2)-agonist but because it has a fast onset of action it can also be used as a relief medication. Objectives To asses the efficacy and safety of formoterol as reliever therapy in comparison to short-acting ...
Cates, CJ, Welsh, EJ
core   +1 more source

Spatial Distribution of (R)-salbutamol in Rat Brain Following Nasal and Intravenous Administration Using DESI-MS

open access: yesPharmaceutics, 2020
Recent studies have shown that β2-Adrenoreceptor is a regulator of the a-synuclein gene driving risk of Parkinson’s disease. The β2-AR agonist (R)-salbutamol, eutomer of rac-salbutamol, may hold therapeutic potential for Parkinson’s
Rui Zhang   +6 more
doaj   +1 more source

INVESTIGATION OF SALBUTAMOL TOLERANCE [PDF]

open access: yesBritish Journal of Clinical Pharmacology, 1974
A double blind cross‐over study was carried out on patients with reversible airways disease attending an out‐patient clinic. Twenty patients were given either salbutamol (200 μg) or propellant by aerosol for two week periods and in another study twelve patients were given identical tablets containing either salbutamol (4 mg) or placebo for four week ...
openaire   +3 more sources

Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events [PDF]

open access: yes, 2009
Epidemiological evidence has suggested a link between beta(2)-agonists and increased asthma mortality. There has been much debate about possible causal links for this association, and whether regular (daily) long-acting beta(2)-agonists are safe ...
Altman   +74 more
core   +1 more source

Home - About - Disclaimer - Privacy